Skip to main content
Premium Trial:

Request an Annual Quote

A Few Touchups?

An Italian cancer researcher is being criminally investigated for fraud, Retraction Watch's Adam Marcus reports. The researcher, Alfredo Fusco from the National Council of Research’s Institute of Experimental Endocrinology and Oncology, allegedly manipulated images in eight papers, in part to get more funding.

According to Marcus, Fusco's work is highly cited and has focused on using microarrays to identify genes with differential expression in thyroid cancer and on studying High Mobility Group A rearrangements in benign and malignant tumors.

Marcus adds that the eight papers in question have not been retracted. "In our experience, the criminal inquiries usually follow the expose of scientific misconduct, not the other way around," he adds.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.